Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by tamarindo1 on Oct 13, 2021 3:39pm

Re-Hiring

I notice that  'Director of  Clinical Development" posn is no longer on the INDEED website.

The other two have "Urgently Hiring"  on their advrts.

Expected start date has 1 nov/21 don't know if that was on there before.
Comment by Infinity on Oct 14, 2021 8:01am
Comment by StevenBirch on Oct 14, 2021 10:05am
I have to disagree with you Infinity about the vaccine research being a long shot, on one point anyway. Yes Pfizer, Moderna and Astrazeneca were there first but all have had their issues and yes they all have the financial might and (corrupt) influence but in medicine doesn't 'better' still beat 'first'?  As you say TLT seems to have the side effect advantage so that ...more  
Comment by Rumpl3StiltSkin on Oct 14, 2021 10:57am
Exactly Steven, There will be other nasty Covid related variants, unfortunetly. So a repeatable, safe, highly effective treatment, immuno-therapeutic, Vaxx. Should be of great value to someone. Maybe Li Ka Shing??
Comment by skys1 on Oct 14, 2021 11:06am
Steven, you are not the only one who beliebes,"theirs is better". Consider - If a medical entity had interest in a small biotech that was developing a novel process to cure cancer and it wanted to make sure they would be the first to gain knowledge of the progress of developing that treatment, a very smart move on the part of that entity (St Mikes/Unity Health), would be to invite TLT to ...more  
Comment by Rumpl3StiltSkin on Oct 14, 2021 1:18pm
When you say Unity Health is that the same as saying Li Ka Shing? or are they like TLT and just sort of sponsored by his organization?
Comment by skys1 on Oct 14, 2021 3:03pm
When this relationship with Unity and St Mikes for that matter was originally announced I did some research on it. Both are part of the Li Ka Shing Foundation. Which is primarily medical and was funded by Li Ka Shing and is alao philanthropic. Some of Senior manasgement come right from Big Pharma so they are well versed in the biotech takeover world, so something like a move on TLT is well within ...more  
Comment by Infinity on Oct 15, 2021 6:55am
I think Theralase is on the verge of a big move very soon.  Based on the ACT test results coming in soon in the 3rd quarterly report due anytime now.  My guess would be that all TLT stock holders will have a GREAT CHRISTMAS and Holiday Season..
Comment by tamarindo1 on Oct 22, 2021 6:28pm
I notice that the last two  Theralase jobs on "INDEED" have disappeared.
Comment by stocksnbonds458 on Oct 23, 2021 9:02am
Tamarindo that is not a good sign
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250